Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
36 studies found for:    " August 22, 2012":" September 21, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Unknown  Sustained Virological Suppression and Improvement of Adverse Events of Switching to Raltegravir Study
Conditions: HIV Infection;   Adverse Drug Reaction;   Quality of Life
Intervention: Drug: Raltegravir switch
22 Completed Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART
Condition: HIV Infection
Intervention: Drug: Panobinostat
23 Completed Assessment of the Effectiveness of New Clinical Guidelines for Differential Diagnosis and Management of Common HIV/AIDS-related Conditions in Mozambique
Conditions: Anemia;   Fever;   HIV Positive
Intervention:
24 Completed Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART)
Condition: HIV-1 Infection
Interventions: Drug: Part A: lenalidomide dose escalation;   Drug: Part B: lenalidomide;   Drug: Part B: lenalidomide placebo
25 Recruiting Rifampin and Nevirapine Interactions in Young Children
Conditions: Tuberculosis;   HIV
Intervention:
26 Recruiting Safety and Acceptability Study of Oral Emtricitabine/Tenofovir Disoproxil Fumarate Tablet and Rectally-Applied Tenofovir Reduced-Glycerin 1% Gel
Condition: HIV
Interventions: Drug: Oral FTC/TDF (Daily Emtricitabine/Tenofovir Disoproxil fumarate Tablet);   Drug: Rectal Daily TFV RG 1% gel (Rectally applied Tenofovir Reduced Glycerin 1% Gel);   Drug: Rectal RAI-associated TFV RG 1% gel (Receptive Anal Intercourse Associated rectally applied Tenofovir Reduced Glycerin 1% Gel)
27 Unknown  A Pilot Study to Assess the Feasibility of Switching, Individuals Receiving Atripla With Continuing Central Nervous System (CNS) Toxicity, to a Fixed Dose Combination of Tenofovir/Emtricitabine/Rilpivirine
Condition: HIV
Intervention: Drug: tenofovir/emtricitabine/rilpivirine
28 Active, not recruiting Rapid Initiation of Antiretroviral Therapy to Promote Early HIV/AIDS Treatment in South Africa (RapIT Study)
Condition: HIV
Intervention: Other: Rapid ART initiation
29 Recruiting Treatment of Acute HIV Infection With Quad Fixed-dose Combination (FDC) Tablet
Condition: HIV
Intervention: Drug: (FDC) ELV/COBI/FTC/TDF
30 Unknown  A Study to Assess Cerebrospinal Fluid INflammatory Markers After Addition of Maraviroc to MONotherapy Darunavir/Ritonavir - The CINAMMON Study
Condition: HIV
Intervention: Drug: maraviroc
31 Recruiting Pilot Study of Diflunisal in HIV-infected Adults
Condition: HIV Infection
Intervention: Drug: Diflunisal
32 Completed Safety Sudy of Atazanavir Capsules in the Treatment of HIV in Patients Ages 6 - 18 Years
Condition: HIV, Pediatric
Interventions: Drug: Atazanavir;   Drug: Ritonavir
33 Recruiting Screening, Brief Intervention, and Referral to Treatment for Offenders
Conditions: Substance Use;   HIV Infections
Interventions: Behavioral: SBIRT;   Behavioral: Control Group
34 Not yet recruiting Raltegravir-based Antiretroviral Therapy for Resistant HIV-1 Infection
Condition: AIDS/HIV PROBLEM
Interventions: Drug: RAL+TDF+LPV/r;   Drug: 3TC+TDF+LPV/r
35 Not yet recruiting Efficacy and Safety of Tenofovir Plus Lamivudine Plus Efavirenz Regimen as First-line Antiretroviral Therapy
Condition: AIDS/HIV PROBLEM
Intervention: Drug: TDF+3TC+EFV
36 Recruiting Protect and Connect: Couple HIV Prevention for Drug Involved Male Offenders
Conditions: Sexually Transmitted Diseases;   Unsafe Sex;   Substance-Related Disorders
Interventions: Behavioral: PACT;   Behavioral: TAU

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-36) Next Page   
Indicates status has not been verified in more than two years